After launching its Mako surgical robot for total knee replacement in 2016, Stryker continues to have a positive position in the robotics market, MiBiz reports.
Here are five takeaways:
1. Stryker President and CEO Kevin Lobo told brokerage analysts, "He was very bullish about the future of robotics technology. Demand for the Mako robot continues to be very strong," according to the MiBiz report.
2. In the third quarter of 2017, Stryker sold 33 Mako robots, with 23 of them sold in the U.S. The Mako robot had a 36 percent lower 30-day complications rate. Complications and readmission costs were both 66 percent lower in the third quarter as well.
3. With the addition of total knee replacement, more than 9,400 procedures have been performed using the Mako robot. Stryker's total knee procedures using the Mako robot grew 50 percent from the second quarter in 2017.
4. The company plans to invest in training surgeons, as well as more clinical studies to provide evidence to support the use of surgical robots.
5. The Mako robot is featured various settings, including hospitals, academic teaching centers, rural hospitals and outpatient centers.